NCT01287481

Brief Summary

This interventional, randomized controlled study seeks to test the effects of an innovative emotional exposure and processing treatment that targets stress resolution, by comparing it with cognitive-behavioral therapy and a Fibromyalgia education comparison condition. The investigators also will test proposed mediators of the intervention, including improved autonomic regulation, and explore which subgroups of patients benefit the most from each approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started May 2011

Typical duration for phase_2

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2010

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 1, 2011

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

March 17, 2016

Status Verified

March 1, 2016

Enrollment Period

4.2 years

First QC Date

November 2, 2010

Last Update Submit

March 15, 2016

Conditions

Keywords

FibromyalgiaBehavioral interventionsPsychological interventions

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

Secondary Outcomes (23)

  • SF-12

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

  • PROMIS Fatigue short form

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

  • Pittsburgh Sleep Quality Index

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

  • Center for Epidemiological Studies - Depression Scale

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

  • Generalized Anxiety Disorder - 7

    Baseline, post-treatment, 6 months post-treatment (primary endpoint), and 12 months post-treatment

  • +18 more secondary outcomes

Study Arms (3)

Stress and Emotions

EXPERIMENTAL

Seeks to reduce stress and physical symptoms by helping individual become aware of their emotions, express them, and resolve emotional difficulties. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.

Behavioral: Stress and Emotions

Thoughts and Behaviors

ACTIVE COMPARATOR

Seeks to help individuals function better and improve symptoms by teaching various cognitive and behavioral skills to manage symptoms of fibromyalgia. It will use techniques such as relaxation training, engaging in pleasant activities, pacing yourself, and changing unhelpful ways of thinking.

Behavioral: Thoughts and Behaviors

Brain and Body

ACTIVE COMPARATOR

Seeks to help individuals improve health by educating about fibromyalgia so that one can better understand and more effectively communicate about their health. It will explain the latest scientific information about fibromyalgia, including its causes, the role of the nervous system and body, various medical and alternative treatments, and how to understand research findings.

Behavioral: Brain and Body

Interventions

Focus on emotions, writing about stress, assertiveness training, role playing new ways to handle relationships, and sharing feelings and experiences with others.

Stress and Emotions

Focus on cognitive and behavioral skills, such as relaxation, increasing pleasant activities, pacing, and changing ways of thinking.

Thoughts and Behaviors
Brain and BodyBEHAVIORAL

Focus on the empowering patients by providing the latest scientific information about fibromyalgia, including causes, the role of the nervous system, and various treatments.

Brain and Body

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet Fibromyalgia (FM) criteria of the American College of Rheumatology (ACR)either:
  • ACR criteria including tender points
  • ACR modified clinical criteria that does not include tender points

You may not qualify if:

  • Co-morbid autoimmune disorders, including rheumatoid arthritis and systemic lupus
  • Other serious medical conditions that can impair health status independent of FM
  • Current psychotic disorders (schizophrenia, bipolar disorder, etc.),dissociative identity (multiple personality) disorder, active suicide risk
  • Alcohol/drug dependence in past 2 years
  • Cognitive impairment or dementia
  • Currently have pending (or recently received - within 2 years) FM pain related disability or workman's compensation
  • Unable to fluently read or converse in English
  • Planning to move from the area in the next 14 months
  • Judgment of principle investigator as not appropriate for this trial or all intervention arms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Michigan Medical Center

Ann Arbor, Michigan, 48106, United States

Location

Wayne State University

Detroit, Michigan, 48202, United States

Location

St. John Providence Hospital

Southfield, Michigan, 48075, United States

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Mark A Lumley, Ph.D.

    Wayne State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 2, 2010

First Posted

February 1, 2011

Study Start

May 1, 2011

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

March 17, 2016

Record last verified: 2016-03

Locations